Informational materials

This section contains key materials for medical professionals interested in advanced, personalized treatment methods. Here you will find the scientific rationale, indications for use, and practical details needed to evaluate the AUTOKINE-SP medical procedure.

The AUTOKINE-SP procedure is an innovative approach of regenerative medicine, in which therapeutic material is obtained from the patient's own (autologous) blood. Under sterile conditions, blood cells are incubated according to a special protocol, activating the production of a unique complex of natural regulatory molecules — autologous cytokines (autokines). The resulting autologous material, plasma enriched with autokines, is injected locally (more often endonasally) and has a targeted therapeutic effect, modulating inflammation and stimulating recovery.
Indications for the procedure cover several key areas:

• Neurology and psychiatry: Autism spectrum disorders (ASD), delayed speech development (endonasal administration to modulate neuroinflammation), neurodegenerative diseases, cerebrovascular encephalopathies, post-stroke rehabilitation, and the effects of traumatic brain injury.
• Allergology and pulmonology: Allergic rhinitis, atopic bronchial asthma, aspirin triad (inhalation and endonasal administration).
  Orthopedics, traumatology and rheumatology: Arthrosis and arthritis, frozen shoulder syndrome, rehabilitation after joint surgery, osteochondrosis, disc protrusion, radiculopathy, tendinitis, plantar fasciitis ("heel spur").

Contraindications are standard for methods using autologous biomaterial and include: acute infections and exacerbations of chronic diseases; autoimmune and oncological diseases; HIV/AIDS; pregnancy and breast-feeding.

The expected results of the procedure are a complex effect: pronounced anti-inflammatory and analgesic effect, stimulation of tissue regeneration and restoration of function, antifibrotic and antiallergic effects. The safety of the method is based on the use of the patient's own biomaterial, which eliminates the risks of infection and allergic reactions. The effectiveness is provided by a natural complex of autologous cytokines that act physiologically. The procedure is applicable for children from 2 years of age (the possibility of use at an earlier age is determined individually by the doctor).

If you are considering the possibility of introducing the AUTOKINE-SP procedure into your clinical practice, we recommend that you consult with our specialists to discuss protocols, training, and partnership terms. Contact us by email or messenger to receive detailed materials and answers to your questions.